You Position: Home > Paper
复发高危肾母细胞瘤六例临床治疗
( views:257, downloads:129 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Pediatric Surgery
- Issue:
- 9
- DOI:
- 10.3760/cma.j.issn.0253-3006.2014.09.020
- Key Word:
- No keyword available
Abstract： 肾母细胞瘤(wilms tumor,WT)是儿童时期常见的恶性肿瘤之一.随着化疗、手术及放疗技术的不断改善,总体生存率已＞90％[1-3],但仍有15％组织分型良好和50％间变型WT复发[4].复发WT的长期生存率按临床危险度不同在10％～80％[5].目前尚无统一的复发WT治疗方案.为进一步了解儿童复发WT的临床诊治特点,现将我院2008年1月至2010年1月收治的复发WT 6例的临床资料总结如下.
- [1]李守林,王军,董勤光,等.术前化疗对肾母细胞瘤瘤体的影响[J].2002,(4).
- [2]黄澄如,孙宁,张潍平,等.双侧肾母细胞瘤的诊治--附11例报告[J].2012,(3).
- [3]de-Kraker Jan,Kelsey Anna,Leuschner Ivo,etc.Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.[J].2002,38(2).
- [4]Perlman E,Haase GM,Beckwith JB,etc.Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.[J].2007,48(5).
- [5]Schenk JP,Furtwangler R,Leuschner I,etc.Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.[J].2011,223(3).
- [6]Reinhard H,Schmidt A,Furtwangler R,etc.Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.[J].2008,20(2).
- [7]Hoffer FA,Stewart CF,Chintagumpala M,etc.Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.[J].2007,25(21).
- [8]Morris E,Krailo MD,Reaman GH,etc.Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.[J].2002,13(3).
- [9]James Miser,Elizabeth Perlman,Paul E. Grundy,etc.Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.[J].2008,50(2).
- [10]Perlman EJ,Grundy P,Malogolowkin M,etc.Management of Wilms' tumour: current practice and future goals.[J].2004,5(1).
- [11]P, Grundy,N, Breslow,D M, Green,etc.Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.[J].1989,7(5).
- [12]Spreafico F,Bisogno G,Collini P,etc.Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.[J].2008,51(1).
- [13]De Ioris MA,Castellano A,Ilari I,etc.Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.[J].2011,47(4).
- [14]Song SY,Park K,Park JO,etc.Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria.[J].2003,33(10).